DoW, Ovarian Cancer, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Posted 4 May 2026 · Closes tomorrow
In plain terms
The US Defense Health Agency funds investigator-initiated research on ovarian cancer from basic laboratory through translational research, excluding clinical trials. Applications with strong research plans and preliminary data are due by 1 October 2026 from US-based academic institutions, companies, and other eligible entities.
A generated summary of the donor's text; the original wording is below.
Summary
Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care.
Distinctive Features: Application must contain strong research plan with sound scientific rational and logical reasoning. Preliminary data are required. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials.
Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, will work synergistically on a single project. The results of this partnering project should significantly advance the research beyond what would be possible through individual efforts.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Who can apply
- academia_research
- private_company
- ngo_cso
- government
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"